Advanced in Esophagitis

Luhua M. Wang

Shenzhen Key Laboratory Of Epigenetics And Precision Medicine For Cancers, Chinese Academic Of Medical Sciences & Peking Union Medical College, 
Shenzhen, CN 
Advanced in Esophagitis
Shenzhen Key Laboratory Of Epigenetics And Precision Medicine For Cancers, Chinese Academic Of Medical Sciences & Peking Union Medical College, 
Shenzhen, CN 
OverviewLocationsClinical Research

Overview

Luhua Wang practices in Shenzhen, China. Wang is rated as an Advanced expert by MediFind in the treatment of Esophagitis. Their top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), Hepatectomy, and Thymectomy.

Their clinical research consists of co-authoring 159 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 10 articles in the study of Esophagitis.

Locations

Shenzhen Key Laboratory Of Epigenetics And Precision Medicine For Cancers, Chinese Academic Of Medical Sciences & Peking Union Medical College, Shenzhen, 518116, China
Other Locations
Chinese Academy Of Medical Sciences & Peking Union Medical College, Beijing, China
Chinese Academy Of Medical Sciences And Peking Union Medical College, Beijing, China
Shihezi, 832000, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Post-Operative Radiation Therapy for Patients With pⅢA-N2 Non-Small Cell Lung Cancer After Complete Resection and Adjuvant Chemotherapy: A Prospective Randomized Phase Ⅲ Study
Post-Operative Radiation Therapy for Patients With pⅢA-N2 Non-Small Cell Lung Cancer After Complete Resection and Adjuvant Chemotherapy: A Prospective Randomized Phase Ⅲ Study
Enrollment Status: Completed
Publish Date: October 05, 2020
Intervention Type: Radiation
Study Phase: Phase 3

159 Total Publications

Cellulose microfiber-mediated mesoscale architecture promotes the expansion of patient-derived lung cancer organoids while preserving their malignant characteristics.
Cellulose microfiber-mediated mesoscale architecture promotes the expansion of patient-derived lung cancer organoids while preserving their malignant characteristics.
Journal: Journal of materials chemistry. B
Published: October 01, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Wang's expertise for a condition
ConditionClose
    View All 19 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile